Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kosea S. Frederick"'
Autor:
Cathrine Leonowens, Vanessa González-Pérez, Mary F. Paine, Michael Fisher, Yolanda Scarlett, Kosea S. Frederick, Emily J. Cox, Dan-Dan Tian
Publikováno v:
Drug Metabolism and Disposition. 47:724-731
Midazolam is a widely used index substrate for assessing effects of xenobiotics on CYP3A activity. A previous study involving human hepatocytes showed the primary route of midazolam metabolism, 1'-hydroxylation, shifted to N-glucuronidation in the pr
Autor:
Dan-Dan, Tian, Cathrine, Leonowens, Emily J, Cox, Vanessa, González-Pérez, Kosea S, Frederick, Yolanda V, Scarlett, Michael B, Fisher, Mary F, Paine
Publikováno v:
Drug Metab Dispos
Midazolam is a widely used index substrate for assessing effects of xenobiotics on CYP3A activity. A previous study involving human hepatocytes showed the primary route of midazolam metabolism, 1′-hydroxylation, shifted to N-glucuronidation in the
Autor:
Steven G. Terra, Mark A. West, Charles J. Rotter, Amit S. Kalgutkar, Robert L. Walsky, Bo Feng, Manthena V.S. Varma, Renato J. Scialis, Kosea S. Frederick, Omar L. Francone, James R. Gosset, Theunis C. Goosen, Danny Chen
Publikováno v:
Xenobiotica. 43:963-972
1. 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778875), an agonist of the peroxisome proliferator-activated receptor alpha, has been evaluated in the clinic to treat dyslipidemia and type 2 diabetes mellitus. Herein, we i
Autor:
John R. Soglia, Hao Sun, Jonathan N. Bauman, Zhuang Miao, Jianke Li, Angel Guzman-Perez, Kenneth J. DiRico, Tim F. Ryder, Scott W. Bagley, Kosea S. Frederick, Bruce M. Bechle, Sabrina X. Zhao, Michael P. Zawistoski, Daniel P. Walker, Kevin K.-C. Liu, Mary Theresa Didiuk, Amit S. Kalgutkar, Joel Morris, Robert M. Oliver, Ryan Michael Kelley, John William Benbow, David A. Griffith, Chandra Prakash
Publikováno v:
Chemical Research in Toxicology. 23:1115-1126
The synthesis and structure-activity relationship studies on 5-trifluoromethylpyrido[4,3-d]pyrimidin-4(3H)-ones as antagonists of the human calcium receptor (CaSR) have been recently disclosed [ Didiuk et al. ( 2009 ) Bioorg. Med. Chem. Lett. 19 , 45
Autor:
Delvin R. Knight, Weifan Weng, Andrew Robertson, Amit S. Kalgutkar, Ronald P. Gladue, Patricia-Ann Bourassa, Kosea S. Frederick, Andrew H. Smith, Robert J. Aiello, Bret D. Perry
Publikováno v:
Atherosclerosis. 208:370-375
Objective The CCR2 receptor plays a crucial role in monocyte recruitment and has been implicated as a contributing factor to atherosclerosis. CCR2 receptor deletion leads to significant inhibition of lesion development. Our objective was to determine
Autor:
Rochelle J. Mireles, Matthew D. Troutman, Bo Feng, Jonathan Chupka, Kosea S. Frederick, Sarah Kempshall, Katherine S. Fenner, Amit S. Kalgutkar
Publikováno v:
Journal of Pharmaceutical Sciences. 98:4914-4927
The utility of the diaminoquinazoline derivative CP-100,356 as an in vivo probe to selectively assess MDR1/BCRP-mediated drug efflux was examined in the rat. CP-100,356 was devoid of inhibition (IC(50) >50 microM) against major human P450 enzymes inc
Autor:
Scott W. Bagley, Hang T. Nguyen, Kosea S. Frederick, Michael P. Zawistoski, Kenneth J. DiRico, Vishwas M. Paralkar, Xiaojing Yang, Hua Gao, Thanh V. Olson, Keith Riccardi, Stephanie Santucci, F. Christopher Bi, Tristan S. Maurer, Matthew Corbett, Daniel P. Walker, Ryan Michael Kelley, Robert M. Oliver, John William Benbow, David R. Healy, Joseph DiBrinno, Amit S. Kalgutkar, Kevin K.-C. Liu, Mei Li, Syed Ahmed, Mary Theresa Didiuk, Joel Morris, Chiliu Chen, William M. Hungerford, Bruce M. Bechle, Yuan Zeng, Jianke Li, Angel Guzman-Perez, David A. Griffith
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:4555-4559
Synthesis and structure-activity relationship (SAR) studies on 5-trifluoromethylpyrido[4,3-d]pyrimidin-4(3H)-ones, a novel class of calcium receptor antagonists is described with particular emphasis on optimization of the pharmacokinetic/pharmacodyna
Autor:
Amit S. Kalgutkar, Edna F. Choo, Heather L. Hatch, Yi-an Bi, Hang T. Nguyen, David B. Duignan, Kosea S. Frederick, Sabrina X. Zhao, Scott D. Campbell, Rouchelle J. Mireles, Bo Feng, Diana C. Kazolias, Ralph E. Davidson
Publikováno v:
Drug Metabolism and Disposition. 35:2111-2118
The role of transporters in the disposition of (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid (CP-671,305), an orally active inhibitor of phosphodiesterase-4, was examined. In bile duct-e
Publikováno v:
The AAPS Journal. 8:E433-E442
Biochanin A (BCA) is a dietary isoflavone present in legumes, most notably red clover, and in many herbal dietary supplements. BCA has been reported to have chemopreventive properties and is metabolized to the isoflavone genistein (GEN), BCA conjugat
Autor:
Amit S. Kalgutkar, Ravi Shanker Garigipati, Lee A. Morehouse, Bruce Allen Lefker, Catherine M. Ambler, Heather L. Hatch, David Austen Perry, Xiao Hu, George Chang, Omar L. Francone, Kosea S. Frederick, Ronald W. Clark
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 44(7)
1. Elaborate studies of cholesteryl ester transfer protein (CETP) polymorphisms and genetic deficiency in humans suggest direct links between CETP, high-density lipoprotein cholesterol (HDL-c) levels and coronary heart diseases. The hypothesis that C